Text Size
36 studies found for:    " September 15, 2010":" October 15, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Recruiting Cohort of Young Adults Infected With HIV Since Birth or During Childhood
Conditions: HIV Infection;   Young Adult
Intervention: Biological: blood sampling, specific biological exams and biobank and self administered questionnaires
22 Completed Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen Repertoires
Conditions: Malaria;   Schistosomiasis;   Hiv Infection
Intervention:
23 Active, not recruiting Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study
Conditions: Hiv Infection;   Lung Cancer
Intervention: Radiation: Low dose computed tomography (CT)
24 Not yet recruiting Prevalence of Liver Fibrosis and Progression of Liver Fibrosis
Condition: HIV Infection and Chronic Alanine Aminotransferase Elevation
Intervention: Other: Fibroscan
25 Recruiting Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
Conditions: Anal Cancer;   Nonneoplastic Condition;   Penile Cancer;   Precancerous Condition
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine;   Other: laboratory biomarker analysis
26 Completed GSK1349572 Hepatic Impairment Study
Conditions: Healthy Subjects;   Hepatic Impairment;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
27 Recruiting ZIAGEN® Post-marketing Surveillance
Condition: Infection, Human Immunodeficiency Virus I
Intervention: Drug: ZIAGEN®
28 Completed A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects
Condition: Infections, Human Immunodeficiency Virus and Tuberculosis
Interventions: Drug: GSK1349572;   Drug: Placebo;   Drug: Iohexol Injection;   Drug: Para-aminohippurate infusion
29 Active, not recruiting HIV-1 Resistance at Screening for HIV Prevention Studies
Condition: HIV
Interventions: Procedure: Laboratory Testing;   Other: Counseling/referral
30 Recruiting Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
Conditions: HIV;   Respiratory Infections;   Fungal Pneumonia;   Viral Pneumonia;   Mycobacteria
Intervention:
31 Active, not recruiting Young Women's CoOp Study
Conditions: HIV;   Sexual Risk;   Sexually Transmitted Diseases;   Substance Abuse;   Violence;   Victimization
Interventions: Behavioral: Young Women's CoOp;   Behavioral: Staying Healthy and Eating Well
32 Active, not recruiting Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
Conditions: HIV;   Cancer
Intervention: Biological: Fluzone High Dose Vaccine Vs Fluzone
33 Completed Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects
Condition: Healthy Volunteers
Interventions: Drug: Abacavir/Lamivudine;   Drug: Lersivirine
34 Recruiting EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)
Condition: Pregnancy Outcome
Intervention:
35 Completed Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects
Condition: Healthy Volunteers
Intervention: Drug: Lersivirine
36 Completed Family Planning Through Dairy Cooperatives
Conditions: The Study Goal is to Assess the Introduction of Sustainable Family Planning/Reproductive Health Information and Services Through;   Land O' Lakes-supported Dairy Cooperatives
Intervention:
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page
† Indicates status has not been verified in more than two years